SABCS: CREATE-X – Capecitabine is efficacious against residual HER2-negative breast cancer

Press/Media: Press / Media

PeriodDec 9 2015

Media coverage

1

Media coverage

  • TitleSABCS: CREATE-X – Capecitabine is efficacious against residual HER2-negative breast cancer
    Media name/outletFrontline Medical News
    CountryUnited States
    Date12/9/15
    PersonsVirginia G Kaklamani